期刊文献+

肺癌T分期与淋巴结转移关系 被引量:8

Relationship between the T staging of the seventh edition and lymph nodes metastasis of lung cancer
原文传递
导出
摘要 目的 探讨新版(第7版)肺癌TNM分期中T新分级与淋巴结转移的关系.方法 对513例非小细胞肺癌原发肿瘤大小及淋巴结转移进行回顾性分析,探讨不同大小原发肿瘤中淋巴结转移的情况.结果 肿瘤最大径≤2 cm(T1a)、2 cm<~≤3 cm(T1b)、3cm< ~≤5 cm(T2a)、5cm<~≤7cm(T2b)、>7 cm(T3)的淋巴结转移率分别为14.47%、28.89%、37.59%、36.37%、37.89%,T1a与T1b,、T2a、T2b、T3间淋巴结转移率有显著性差异.N1淋巴结转移各组间P<0.05.N2淋巴结转移例数各组间P<0.05,T1a与T1b、T2a、T2b间淋巴结转移率比较差异有显著性.T1b与T2a、T2b、T3之间差别有显著性.结论 新版TNM分期中肿瘤大小的新分级与淋巴结转移率有关,其差异主要在N2上;T1a淋巴结转移率低. Objective The new lung cancer TNM staging for T staging the new grading.The aim of this study was to investigate the relationship between the T staging and grading of the Seventh Edition and lymph node metastasis of lung cancer.Methods In 513 cases of non-small cell lung cancer primary tumor size and lymph node metastasis were analyzed,and explore the situation of different size,lymph node metastasis in primary tumors.To analyse the collected data with SPSS software.Results The total lymph node metastatic rates in tumor diameter biggest ≤2 cm(T1a) 、2 cm < ~ ≤3 cm(T1b) 、3 cm < ~ ≤5 cm (T2a) 、5 cm < ~ ≤7 cm(T2b) 、> 7 cm(T3) were 14.47% 、28.89% 、37.59% 、36.37% 、37.89%.The lymph node metastatic rate of T1a was significantly different,compared with T1b 、T2a 、T2b and T3,respectively.There were no differences between every two groups of T1b,T2a,T2b and T3.The N1 metastaic rates of T1a 、T1b 、T2a 、T2b 、T3 were compared by chi-square(P <0.05),The lymph node metastatic rates of T1a and T2a (P =0.001),T1a and T2b (P =0.024).The N2 metastaic rates of T1a 、T1b 、T2a 、T2b 、T3 were compared by chi-square(P <0.05),The lymph node metastatic rate of T 1 a was significantly different,compared with T1b 、T2a and T2b,respectively.The lymph node metastatic rate of T1 b was significantly different,compared with T2a 、T2b and T3,respectively.Conclusion The new T staging of tumor the size of the new classification is associated with lymph node metastasis rate,especially in N2.low T la lymph node metastasis rate.
出处 《中华胸心血管外科杂志》 CSCD 北大核心 2014年第3期129-132,共4页 Chinese Journal of Thoracic and Cardiovascular Surgery
关键词 肺肿瘤 肿瘤分期 肿瘤转移 淋巴结 Lung neoplasm Neoplasm staging Neoplasm metastasis Lymph nodes
  • 相关文献

参考文献17

二级参考文献165

共引文献220

同被引文献80

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA Cancer J Clin, 2011, 61(2): 69-90.
  • 2Riquet M, Arame A, Foueault C, et al. Prognostic classifica- tions of lymph node involvement in lung cancer and current International Association for the Study of Lung Cancer de- scriptive classification in zones [J].Interact Cardiovasc Tho- rac Surg, 2010,11(3): 260-2604.
  • 3Lee PC, Port JL, Korst RJ, et al. Risk factors for occult me- diastinal metastases in clinical stage I non-small cell lung cancer[J]. Ann ThoraeSurg, 2007,84(1):177-181.
  • 4Sachs S, Bilfinger TV, Komaroff E, et al. Increased stand- ardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer [J]. Clin Lung Cancer, 2005, 6(5): 310-313.
  • 5Lee JW, Kang CM, Choi HJ, et al. Prognostic value of met- abolic tumor volume and total lesion glycolysis on preopera- tive 18F-FDG PET/CT in patients with pancreatic cancer[J].J Nucl Med, 2014, 55(8): 898-904.
  • 6Chung HW, Lee KY, Kim HJ, et al. FDG PET/CT meta- bolic tumor volume and total lesion glycolysis predict progno- sis in patients with advanced lung adenocarcinoma [J]. J Cancer Res Clin Oncol, 2014,140(1) : 89-98.
  • 7Xu HX, Chen T, Wang WQ, et al. Metabolic tumour bur- den assessed by 18F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection [J]. Eur J Nucl Med Mol Imaging, 2014, 41(6) : 1093-102.
  • 8Im HJ, Pak K, Cheon GJ, et al. Prognostic value of volu metric parameters of F-FDG PET in non-small-cell lung canc er: a meta-analysis [J]. Eur J Nucl Med Mol Imaging, 2014, 42(2) : 241-251.
  • 9Mehta G, Chander A, Huang C, et al. Feasibility study of FDG PET/CT-derived primary tumour glycolysis as a prog- nostic indicator of survival in patients with non-small-cell lung cancer [J]. Clin Radiol, 2014, 69(3): 268-274.
  • 10Hyun SH, Ahn HK, Kim H, et al. Volume-based assess- ment by lSF-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer[J]. Eur J Nucl Med Mol Imaging, 2014, 41(1): 50-58.

引证文献8

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部